These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10417291)

  • 21. Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort.
    Falchi M; Spector TD; Perks U; Kato BS; Bataille V
    Hum Mol Genet; 2006 Oct; 15(20):2975-9. PubMed ID: 16928783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
    Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
    Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial malignant melanoma and atypical disseminated moles (BK-mole syndrome)].
    Hundeiker M; Ruppel R; Schmitt H
    Hautarzt; 1980 Jan; 31(1):42-6. PubMed ID: 7390807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma.
    Höiom V; Tuominen R; Hansson J
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1076-84. PubMed ID: 21901783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors.
    Piepkorn M
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):705-22; quiz 723-6. PubMed ID: 10775844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data.
    Sham PC; Cherny SS; Purcell S; Hewitt JK
    Am J Hum Genet; 2000 May; 66(5):1616-30. PubMed ID: 10762547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.
    Ghiorzo P; Villaggio B; Sementa AR; Hansson J; Platz A; Nicoló G; Spina B; Canepa M; Palmer JM; Hayward NK; Bianchi-Scarrà G
    Hum Pathol; 2004 Jan; 35(1):25-33. PubMed ID: 14745721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New developments in melanoma genetics.
    Hayward N
    Curr Oncol Rep; 2000 Jul; 2(4):300-6. PubMed ID: 11122857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
    Taylor NJ; Mitra N; Goldstein AM; Tucker MA; Avril MF; Azizi E; Bergman W; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes AM; Ghiorzo P; Grazziotin TC; Hansson J; Harland M; Hayward NK; Hocevar M; Höiom V; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer JM; Perić B; Pjanova D; Pritchard A; Puig S; van der Stoep N; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
    J Invest Dermatol; 2017 Dec; 137(12):2606-2612. PubMed ID: 28830827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases.
    Levanat S; Situm M; Crnić I; Marasović D; Puizina-Ivić N; Pokupcić N; Musani V; Komar A; Kubat M; Furac I; Karija-Vlahović M; Krizanac S
    Croat Med J; 2003 Aug; 44(4):418-24. PubMed ID: 12950144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.
    Bertram CG; Gaut RM; Barrett JH; Pinney E; Whitaker L; Turner F; Bataille V; Dos Santos Silva I; J Swerdlow A; Bishop DT; Newton Bishop JA
    J Invest Dermatol; 2002 Oct; 119(4):961-5. PubMed ID: 12406345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of melanoma in a case-control study of twins (United States).
    Cockburn M; Black W; McKelvey W; Mack T
    Cancer Causes Control; 2001 Sep; 12(7):615-25. PubMed ID: 11552709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
    Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDKN2A region polymorphism and genetic susceptibility to melanoma in the melim swine model of familial melanoma.
    Le Chalony C; Renard C; Vincent-Naulleau S; Crechet F; Leplat JJ; Tricaud Y; Horak V; Gruand J; Le Roy P; Frelat G; Geffrotin C
    Int J Cancer; 2003 Feb; 103(5):631-5. PubMed ID: 12494470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
    Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
    Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma.
    Ung-Juurlink C
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):461-2. PubMed ID: 10507913
    [No Abstract]   [Full Text] [Related]  

  • 38. Sib-pair linkage analysis applied to pedigrees with melanoma and dysplastic nevi.
    Bailey-Wilson JE; Dobbins TE
    Cytogenet Cell Genet; 1992; 59(2-3):176-8. PubMed ID: 1737492
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutation analysis of the CDKN2A promoter in Australian melanoma families.
    Pollock PM; Stark MS; Palmer JM; Walters MK; Aitken JF; Martin NG; Hayward NK
    Genes Chromosomes Cancer; 2001 Sep; 32(1):89-94. PubMed ID: 11477665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
    Barnhill RL
    Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.